SEC Form 4 · accession 0001513162-17-000256
Anixa Biosciences Inc · ANIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Arnold M Baskies
Director
Period of report
Sep 6, 2017
Accepted (ET)
Sep 8, 2017 · 6:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000715446
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1,F2 | $0.67 | Sep 6, 2017 | A | 20,000 | A | — | Sep 6, 2027 | Common Stock | 20,000 | 20,000 | D |
| Employee Stock OptionF3,F4 | $3.13 | Sep 6, 2017 | D | 6,000 | D | — | Aug 23, 2026 | Common Stock | 6,000 | 0 | D |
| Employee Stock OptionF3,F4 | $0.67 | Sep 6, 2017 | A | 6,000 | A | — | Aug 23, 2026 | Common Stock | 6,000 | 6,000 | D |
| Employee Stock OptionF3,F5 | $5.30 | Sep 6, 2017 | D | 12,000 | D | — | Jan 3, 2027 | Common Stock | 12,000 | 0 | D |
| Employee Stock OptionF3,F5 | $0.67 | Sep 6, 2017 | A | 12,000 | A | — | Jan 3, 2027 | Common Stock | 12,000 | 12,000 | D |
Explanation of responses
- F1Right-To-Buy, pursuant to the ITUS Corporation 2010 Share Incentive Plan.
- F2The options vest and become exercisable as follows: a) 10,000 shares shall be vested and exercisable upon grant; b) 8,888 shares shall vest and become exercisable in eight (8) consecutive quarterly installments of 1,111 shares each on the last day of each fiscal quarter, beginning November 30, 2018 and continuing through August 31, 2019; and c) the remaining 1,112 shares shall vest and become exercisable on November 30, 2019.
- F3These transactions involved an amendment of outstanding stock options for the sole purpose of lowering the exercise price, resulting in the deemed cancellation of the "old" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options.
- F4The option was originally granted on August 23, 2016 and vested 50% on September 30, 2016 and 50% on December 31, 2016.
- F5The option was originally granted on January 3, 2017 and vests and become exercisable in four (4) equal installments on each March 31, 2017, June 30, 2017, September 30, 2017 and December 31, 2017.